Michael Osthoff

Trials

Studies that name Michael Osthoff as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:06 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT05689450 · Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

  University Hospital, Basel, Switzerland · completed · Febrile Neutropenia (FN) · principal investigator
• Ph2
  NCT05655091 · Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection

  University Hospital, Basel, Switzerland · recruiting · Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) · principal investigator
• N/A
  NCT05300425 · Seroprevalence of Leptospirosis in Val Müstair, Switzerland

  University Hospital, Basel, Switzerland · completed · Leptospirosis, Hepatitis E Virus Infection, Tularemia · principal investigator
• Ph2
  NCT05145283 · Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation

  University Hospital, Basel, Switzerland · completed · Acute Ischemic Stroke, Acute Renal Injury · principal investigator
• N/A
  NCT05127980 · Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

  University Hospital, Basel, Switzerland · recruiting · Epstein-Barr Virus (EBV) Infection · principal investigator
• N/A
  NCT04503252 · Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus

  University Hospital, Basel, Switzerland · completed · Staphylococcus Aureus Infection · principal investigator
• Ph2
  NCT04414631 · Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

  University Hospital, Basel, Switzerland · terminated · Coronavirus Infections · principal investigator
• Ph2
  NCT02869347 · Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects

  University Hospital, Basel, Switzerland · completed · Acute Kidney Injury · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.